Skip to Content

FMX101 Approval Status

FDA Approved: No
Brand name: FMX101
Generic name: minocycline
Dosage form: Foam
Company: Foamix Pharmaceuticals
Treatment for: Acne

FMX101 (minocycline) is a topical foam formulation of minocycline in development for the treatment of moderate-to-severe acne vulgaris.

Development Status and FDA Approval Process for FMX101

Mar  7, 2019Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
Dec 21, 2018Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
May  1, 2017Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.